Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
9.82
+0.23 (2.40%)
At close: Nov 13, 2026, 4:00 PM EST
9.48
-0.34 (-3.43%)
After-hours: Nov 13, 2026, 7:30 PM EST
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $163.03 million as of November 13, 2026. It is the 21,750th most valuable company in the world and the 3,680th biggest in the United States. Its market cap has increased by 136.27% in one year.
Market Cap
163.03M
Enterprise Value
30.55M
1-Year Change
136.27%
Global Rank
Country Rank
#3,680 United States
Category
ChartMarket Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $336.80M to $163.03M, a decrease of -51.60%. That is a compound annual growth rate of -8.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 163.00M | 65.48% |
| Dec 31, 2025 | 98.50M | -35.07% |
| Dec 31, 2024 | 151.70M | -41.99% |
| Dec 29, 2023 | 261.50M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -17.85% |
| Dec 31, 2020 | 838.10M | 229.96% |
| Dec 31, 2019 | 254.00M | 23.24% |
| Dec 31, 2018 | 206.10M | -38.81% |
| Sep 27, 2018 | 336.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 168.47M |
| Oramed Pharmaceuticals | 167.64M |
| Invivyd | 167.22M |
| Humacyte | 165.40M |
| Zentalis Pharmaceuticals | 165.09M |
| Veraxa Biotech AG | 162.62M |
| Fate Therapeutics | 160.56M |
| Upstream Bio | 156.76M |